Ohnologs are overrepresented in pathogenic copy number mutations.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
McLysaght, AoifeMakino, Takashi
Grayton, Hannah M
Tropeano, Maria
Mitchell, Kevin J
Vassos, Evangelos
Collier, David A
Issue Date
2014-01-07
Metadata
Show full item recordCitation
Natl. Acad. Sci. U.S.A. 2014, 111 (1):361-6Abstract
A number of rare copy number variants (CNVs), including both deletions and duplications, have been associated with developmental disorders, including schizophrenia, autism, intellectual disability, and epilepsy. Pathogenicity may derive from dosage sensitivity of one or more genes contained within the CNV locus. To understand pathophysiology, the specific disease-causing gene(s) within each CNV need to be identified. In the present study, we test the hypothesis that ohnologs (genes retained after ancestral whole-genome duplication events, which are frequently dosage sensitive) are overrepresented in pathogenic CNVs. We selected three sets of genes implicated in copy number pathogenicity: (i) genes mapping within rare disease-associated CNVs, (ii) genes within de novo CNVs under negative genetic selection, and (iii) genes identified by clinical array comparative genome hybridization studies as potentially pathogenic. We compared the proportion of ohnologs between these gene sets and control genes, mapping to CNVs not known to be disease associated. We found that ohnologs are significantly overrepresented in genes mapping to pathogenic CNVs, irrespective of how CNVs were identified, with over 90% containing an ohnolog, compared with control CNVs >100 kb, where only about 30% contained an ohnolog. In some CNVs, such as del15p11.2 (CYFIP1) and dup/del16p13.11 (NDE1), the most plausible prior candidate gene was also an ohnolog, as were the genes VIPR2 and NRXN1, each found in short CNVs containing no other genes. Our results support the hypothesis that ohnologs represent critical dosage-sensitive elements of the genome, possibly responsible for some of the deleterious phenotypes observed for pathogenic CNVs and as such are readily identifiable candidate genes for further study.Additional Links
http://dx.doi.org/ 10.1073/pnas.1309324111http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890797/
Rights
openAccessae974a485f413a2113503eed53cd6c53
10.1073/pnas.1309324111
Scopus Count
Collections
Related articles
- Male-biased autosomal effect of 16p13.11 copy number variation in neurodevelopmental disorders.
- Authors: Tropeano M, Ahn JW, Dobson RJ, Breen G, Rucker J, Dixit A, Pal DK, McGuffin P, Farmer A, White PS, Andrieux J, Vassos E, Ogilvie CM, Curran S, Collier DA
- Issue date: 2013
- Application of array comparative genomic hybridization in 102 patients with epilepsy and additional neurodevelopmental disorders.
- Authors: Bartnik M, Szczepanik E, Derwińska K, Wiśniowiecka-Kowalnik B, Gambin T, Sykulski M, Ziemkiewicz K, Kędzior M, Gos M, Hoffman-Zacharska D, Mazurczak T, Jeziorek A, Antczak-Marach D, Rudzka-Dybała M, Mazurkiewicz H, Goszczańska-Ciuchta A, Zalewska-Miszkurka Z, Terczyńska I, Sobierajewicz M, Shaw CA, Gambin A, Mierzewska H, Mazurczak T, Obersztyn E, Bocian E, Stankiewicz P
- Issue date: 2012 Oct
- Inference of Causative Genes for Alzheimer's Disease Due to Dosage Imbalance.
- Authors: Sekine M, Makino T
- Issue date: 2017 Sep 1
- Prevalence of Pathogenic Copy Number Variation in Adults With Pediatric-Onset Epilepsy and Intellectual Disability.
- Authors: Borlot F, Regan BM, Bassett AS, Stavropoulos DJ, Andrade DM
- Issue date: 2017 Nov 1
- The clinical benefit of array-based comparative genomic hybridization for detection of copy number variants in Czech children with intellectual disability and developmental delay.
- Authors: Wayhelova M, Smetana J, Vallova V, Hladilkova E, Filkova H, Hanakova M, Vilemova M, Nikolova P, Gromesova B, Gaillyova R, Kuglik P
- Issue date: 2019 Jul 23